| Name | Advanced Oncotherapy |
|---|---|
| Epic | AVO |
| Isin | GB00BD6SX109 |
| Industry | Medical Equipment and Services |
| Latest share price | 1.93p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £10.44 | Debt ratio | n/a |
| Shares in issue | 542.57 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -51.44 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -7.71 | 52-week high / low | 1.75p / 25.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Advanced Oncotherapy |
|---|---|
| Address | 143 Harley Street, Ground Floor, London, United Kingdom, W1G 6BH |
| Telephone | 020 7034 1949 |
| Website | www.avoplc.com |
| Director | Position |
|---|---|
| Mr Nicolas Serandour | CEO |
| Mr Nick Plowman | Non-Executive Director |
| Ms Lori Cross | Non-Executive Director |
| Mrs RenHua Zhang | Non-Executive Director |
| Mr Michael Bradfield | Non-Executive Director |
| Professor Steve Myers OBE | Non-Executive Director |
| Mr Enrico Cipro Vanni | Non-Executive Director |
| Mr Hans von Celsing | Non-Executive Director |
| Dr Michael J Sinclair | Executive Chairman |
| Assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Reporting date | 31/12/21 | 31/12/20 | 31/12/19 |
| Intangible asssets and goodwill | 68.58 | 56.87 | 49.18 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 110.56 | 95.95 | 88.63 |
| Inventory / work in progress | 25.83 | 22.14 | 15.05 |
| Trade and other receivables | 0.64 | 1.89 | 2.14 |
| Cash and equivalents | 4.26 | 2.32 | 3.24 |
| Other current assets and asset held for resale | n/a | n/a | 1.77 |
| Total of all assets | 141.29 | 122.29 | 110.82 |
| Liabilities £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Short term liabilities | 16.12 | 19.21 | 6.48 |
| Long term liabilities | 63.8 | 58.94 | 61.41 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 79.92 | 78.15 | 67.89 |
| Net assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net assets | 61.37 | 44.14 | 42.94 |
| Equity £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Share capital | 112.9 | 83.36 | 61.11 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -151.5 | -122.27 | -98.5 |
| Share premium account | 71.09 | 61.44 | 60.45 |
| Total equity | 61.37 | 44.14 | 42.94 |
| Income £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -23.74 | -20.27 | -20.66 |
| Pre-tax profit | -29.49 | -25.3 | -21.88 |